Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001654954-17-003773
Filing Date
2017-04-28
Accepted
2017-04-28 16:00:40
Documents
4
Period of Report
2017-06-16
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT v1042817_def14a.htm DEF 14A 496491
2 IMAGE proxycard1.jpg GRAPHIC 116500
3 IMAGE proxycard2.jpg GRAPHIC 92427
4 IMAGE v1042817_def14a000.jpg GRAPHIC 4286
  Complete submission text file 0001654954-17-003773.txt   791776
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32639 | Film No.: 17795293
SIC: 2834 Pharmaceutical Preparations